| WB | 咨询技术 | Human,Mouse,Rat |
| IF | 咨询技术 | Human,Mouse,Rat |
| IHC | IHC:1/100-1/200;IHF:1/50-1/200 | Human,Mouse,Rat |
| ICC | 1/50-1/200 | Human,Mouse,Rat |
| FCM | 咨询技术 | Human,Mouse,Rat |
| Elisa | 咨询技术 | Human,Mouse,Rat |
| Aliases | Mouse, Rat, Human;SEC62 |
| WB Predicted band size | Calculated MW: 46 kDa ; Observed MW: 50 kDa |
| Host/Isotype | Rabbit IgG |
| Antibody Type | Primary antibody |
| Storage | Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles. |
| Species Reactivity | Human,Mouse,Rat |
| Immunogen | A synthesized peptide derived from human SEC62 |
| Formulation | Purified antibody in PBS with 0.05% sodium azide,0.05% BSA and 50% glycerol. |
+ +
以下是关于SEC62抗体的3-4篇参考文献的简要总结：
---
1. **"SEC62 is a prognostic marker contributing to proliferation and invasion in human lung adenocarcinoma"**
*Authors: Linxweiler et al. (2017)*
**摘要**：本研究通过免疫组织化学(IHC)和Western blot分析，发现SEC62在非小细胞肺癌(NSCLC)中高表达，并与肿瘤增殖、转移及患者不良预后相关。研究利用特异性SEC62抗体验证其作为潜在生物标志物的价值。
2. **"SEC62 encodes a component of the endoplasmic reticulum translocation complex in mammalian cells"**
*Authors: Lang et al. (2012)*
**摘要**：文章阐明SEC62蛋白在内质网(ER)介导的蛋白质转运中的作用，通过免疫荧光和共沉淀实验(使用SEC62抗体)证明其与SEC63形成复合体，对维持ER稳态至关重要。
3. **"Clinical relevance of SEC62 overexpression in metastatic prostate cancer"**
*Authors: Greiner et al. (2021)*
**摘要**：研究利用SEC62抗体对前列腺癌组织样本进行染色，发现SEC62过表达与肿瘤转移及患者总生存率降低显著相关，提示其可作为治疗靶点或预后指标。
4. **"Development and validation of a SEC62-specific antibody for diagnostic applications in solid tumors"**
*Authors: Müller et al. (2015)*
**摘要**：报道了一种高特异性SEC62抗体的开发流程，通过ELISA、免疫印迹和免疫组化验证其在多种癌症(如乳腺癌、肝癌)中的诊断适用性，强调其在区分恶性与正常组织中的潜力。
---
以上文献涵盖SEC62在癌症机制、分子功能及抗体开发中的应用，均以SEC62抗体为核心实验工具。如需具体文献链接或补充，可进一步提供数据库检索关键词(如PMID/DOI)。
SEC62 (also known as translocation protein SEC62) is a key component of the endoplasmic reticulum (ER) membrane, playing a critical role in protein translocation and post-translational transport. It forms part of the SEC61 translocon complex, which facilitates the co-translational insertion of nascent polypeptides into the ER and supports the retrograde transport of misfolded proteins for ER-associated degradation (ERAD). SEC62 is particularly vital in maintaining ER homeostasis and cellular stress responses.
SEC62 antibodies are immunological tools used to detect and study this protein in various research contexts. These antibodies are typically developed in hosts like rabbits or mice, targeting specific epitopes of human SEC62. They enable applications such as Western blotting, immunofluorescence, and immunohistochemistry to investigate SEC62 expression, localization, and interactions in cell lines or tissue samples. Dysregulation of SEC62 has been implicated in cancers, including prostate, lung, and thyroid cancers, where its overexpression is linked to tumor progression, metastasis, and therapy resistance. SEC62 antibodies thus serve as valuable reagents in cancer research, helping to explore its role as a potential biomarker or therapeutic target. Commercial SEC62 antibodies are often validated for specificity using knockout cell lines or siRNA-mediated silencing. Researchers rely on these antibodies to advance understanding of ER biology, protein quality control mechanisms, and cancer pathophysiology.
×
